Children’s Depression Rating Scale

Nefazodone is not approved by the FDA for use in children, and the literature on its efficacy in the pediatric population is limited. A small case study of children and adolescents who suffered from treatment-refractory depressive disorders (n = 7 mean age of 12.4) were treated with a mean daily dose of 357 151 mg (3.4 mg/kg) for 13 8 weeks. Over half of the subjects (4/7) were judged to be much to very much improved as rated by the Clinical Global Impression (CGI) (Wilens et al., 1997). More recently, an open-label study of nefazodone in children and adolescents (n = 28) with depression yielded significant improvement in depressive symptoms as measured by the Children s Depression Rating Scale, Revised (Findling et al., 2000). 

Children s Depression Rating Scale-Revised (CDRS-R)... 

Children s Depression Inventory Multi-Health Systems Inc., 908 Niagra Falls Blvd., North Tonowanda, NY 14120-2060 (www.mhs.com) Children s Depression Rating Scale-Revised Western Psychological Services, 12031 Wilshire Blvd., Los Angeles, CA 90025-1251 (www.wpspublish.com)... 

Poznansky, E. and Mokros, H.B. (1999) Children s Depression Rating Scale—Revised. Los Angeles Western Psychological Services. 

---